Literature DB >> 23430346

Spinal cord metastasis in a patient treated with bevacizumab for glioblastoma.

Anna J Lomax1, Costas K Yannakou, Mark A Rosenthal.   

Abstract

Spinal metastases from glioblastoma are extremely rare and may be misdiagnosed leading to a delay in investigation and treatment. Patient outcomes are poor with a high morbidity and mortality. Metastases are seen in the context of increasing survival due to improvements in glioblastoma therapies. We report a case of a patient developing a thoracic spinal cord metastasis while receiving anti-angiogenesis therapy with bevacizumab.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23430346     DOI： 10.1007/s11523-013-0270-0

Source DB:  PubMed          Journal:  Target Oncol        ISSN： 1776-2596            Impact factor:   4.493


  13 in total

1.  Brain metastases in hormone refractory prostate cancer: a changing natural history?

Authors:  R Roberts-Thomson; M A Rosenthal; M Gonzales; K Drummond
Journal:  Intern Med J       Date:  2009-03       Impact factor: 2.048

2.  High-dose antiangiogenic therapy for glioblastoma: less may be more?

Authors:  John F de Groot
Journal:  Clin Cancer Res       Date:  2011-08-18       Impact factor: 12.531

Review 3.  Systematic review of primary intracranial glioblastoma multiforme with symptomatic spinal metastases, with two illustrative patients.

Authors:  Mehdi Shahideh; Aria Fallah; David G Munoz; R Loch Macdonald
Journal:  J Clin Neurosci       Date:  2012-06-16       Impact factor: 1.961

Review 4.  Spinal leptomeningeal metastasis from cerebral glioblastoma multiforme presenting with radicular pain: case report and literature review.

Authors:  S Alatakis; G M Malham; C Thien
Journal:  Surg Neurol       Date:  2001-07

5.  Spinal metastasis of glioblastoma multiforme: an uncommon suspect?

Authors:  Theodossios A Birbilis; Georgios K Matis; Savvas G Eleftheriadis; Efthimia N Theodoropoulou; Efthimios Sivridis
Journal:  Spine (Phila Pa 1976)       Date:  2010-04-01       Impact factor: 3.468

6.  Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma.

Authors:  Olivier Keunen; Mikael Johansson; Anaïs Oudin; Morgane Sanzey; Siti A Abdul Rahim; Fred Fack; Frits Thorsen; Torfinn Taxt; Michal Bartos; Radovan Jirik; Hrvoje Miletic; Jian Wang; Daniel Stieber; Linda Stuhr; Ingrid Moen; Cecilie Brekke Rygh; Rolf Bjerkvig; Simone P Niclou
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-14       Impact factor: 11.205

Review 7.  Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme.

Authors:  Joost J C Verhoeff; Olaf van Tellingen; An Claes; Lukas J A Stalpers; Myra E van Linde; Dirk J Richel; William P J Leenders; Wouter R van Furth
Journal:  BMC Cancer       Date:  2009-12-16       Impact factor: 4.430

8.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

Authors:  Roger Stupp; Monika E Hegi; Warren P Mason; Martin J van den Bent; Martin J B Taphoorn; Robert C Janzer; Samuel K Ludwin; Anouk Allgeier; Barbara Fisher; Karl Belanger; Peter Hau; Alba A Brandes; Johanna Gijtenbeek; Christine Marosi; Charles J Vecht; Karima Mokhtari; Pieter Wesseling; Salvador Villa; Elizabeth Eisenhauer; Thierry Gorlia; Michael Weller; Denis Lacombe; J Gregory Cairncross; René-Olivier Mirimanoff
Journal:  Lancet Oncol       Date:  2009-03-09       Impact factor: 41.316

9.  Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma.

Authors:  Henry S Friedman; Michael D Prados; Patrick Y Wen; Tom Mikkelsen; David Schiff; Lauren E Abrey; W K Alfred Yung; Nina Paleologos; Martin K Nicholas; Randy Jensen; James Vredenburgh; Jane Huang; Maoxia Zheng; Timothy Cloughesy
Journal:  J Clin Oncol       Date:  2009-08-31       Impact factor: 44.544

10.  Bevacizumab for the treatment of recurrent glioblastoma.

Authors:  Marc C Chamberlain
Journal:  Clin Med Insights Oncol       Date:  2011-05-02
View more
  6 in total

Review 1.  Extraneural metastases in glioblastoma patients: two cases with YKL-40-positive glioblastomas and a meta-analysis of the literature.

Authors:  Elena Anghileri; Anghileri Elena; Melina Castiglione; Castiglione Melina; Raffaele Nunziata; Nunziata Raffaele; Carlo Boffano; Boffano Carlo; Vittoria Nazzi; Nazzi Vittoria; Francesco Acerbi; Acerbi Francesco; Gaetano Finocchiaro; Finocchiaro Gaetano; Marica Eoli; Eoli Marica
Journal:  Neurosurg Rev       Date:  2015-07-28       Impact factor: 3.042

2.  Brain Stem and Entire Spinal Leptomeningeal Dissemination of Supratentorial Glioblastoma Multiforme in a Patient during Postoperative Radiochemotherapy: Case Report and Review of the Literatures.

Authors:  Xiangyi Kong; Yu Wang; Shuai Liu; Keyin Chen; Qiangyi Zhou; Chengrui Yan; Huayu He; Jun Gao; Jian Guan; Yi Yang; Yongning Li; Bing Xing; Renzhi Wang; Wenbin Ma
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

3.  Extensive Pachymeningeal Dissemination of Glioblastoma Mimicking Chronic Subdural Hematoma: A Case Report.

Authors:  Jiwook Lee; Mee Seon Kim; Young Zoon Kim
Journal:  Brain Tumor Res Treat       Date:  2019-04

Review 4.  Intracranial dissemination of glioblastoma multiforme: a case report and literature review.

Authors:  Keke Zhang; Yihang Yang; Jianfeng Zhuang; Gengyin Guo; Xin Chao; Zhen Zhang
Journal:  J Int Med Res       Date:  2022-07       Impact factor: 1.573

5.  Spinal Intradural Intramedullary Dissemination in the Absence of Intracranial Relapse of a Previously Radically Treated Temporal Lobe Glioblastoma Multiforme.

Authors:  Lucas Serrano; Eleftherios Archavlis; Elke Januschek; Pavel Timofeev; Peter Ulrich
Journal:  Case Rep Oncol       Date:  2017-03-29

6.  Secondary glioblastoma metastasis outside the central nervous system in a young HIV-infected patient.

Authors:  Leonardo Fonseca Rodrigues; Aline Helen da Silva Camacho; Tania Cristina Leite de Sampaio E Spohr
Journal:  Ther Adv Med Oncol       Date:  2020-05-18       Impact factor: 8.168
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.